Ignite Creation Date:
2024-05-06 @ 4:32 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05016349
Status:
UNKNOWN
Last Update Posted:
2021-08-23
First Post:
2021-08-17
Brief Title:
Investigating the Potential Role of a Novel Quadrate Combination Therapy MifepristoneAntiprogestrone Tamoxifen Retinoic Acid and Cannabidiol Selective Cyp 26 Inhibitor for Treating Early Breast Cancer
Sponsor:
Organization:
Kafrelsheikh University
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
160
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: